Literature DB >> 29079449

Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Yasuhiko Kubota1, Aaron R Folsom2, Kunihiro Matsushita3, David Couper4, Weihong Tang2.   

Abstract

BACKGROUND AND AIMS: No prospective study has investigated whether individuals with respiratory impairments, including chronic obstructive pulmonary disease (COPD) and restrictive lung disease (RLD), are at increased risk of abdominal aortic aneurysm (AAA). We aimed to prospectively investigate whether those respiratory impairments are associated with increased AAA risk.
METHODS: In 1987-1989, the Atherosclerosis Risk in Communities (ARIC) study followed 14,269 participants aged 45-64 years, without a history of AAA surgery, through 2011. Participants were classified into four groups, "COPD" [forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <lower limit of normal (LLN)], "RLD" (FEV1/FVC ≥ LLN and FVC < LLN), "respiratory symptoms with normal spirometry" (without RLD or COPD), and "normal" (without respiratory symptoms, RLD or COPD, reference group).
RESULTS: During the 284,969 person-years of follow-up, 534 incident AAA events were documented. In an age, sex, and race-adjusted proportional hazards model, individuals with respiratory impairments had a significantly higher risk of AAA than the normal reference group. After adjustment for AAA risk factors, including smoking status and pack-years of smoking, AAA risk was no longer significant in the respiratory symptoms with normal spirometry group [HR (95% CI), 1.25 (0.98-1.60)], but was still increased in the other two groups [RLD: 1.45 (1.04-2.02) and COPD: 1.66 (1.34-2.05)]. Moreover, continuous measures of FEV1/FVC, FEV1 and FVC were associated inversely with risk of AAA.
CONCLUSIONS: In the prospective population-based cohort study, obstructive and restrictive spirometric patterns were associated with increased risk of AAA independent of smoking, suggesting that COPD and RLD may increase the risk of AAA.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; COPD; Epidemiology; Lung function

Mesh:

Year:  2017        PMID: 29079449      PMCID: PMC5785925          DOI: 10.1016/j.atherosclerosis.2017.10.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  38 in total

1.  Screening for abdominal aortic aneurysm: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Left ventricular hypertrophy and abdominal aorta size in essential hypertension.

Authors:  Cesare Cuspidi; Stefano Meani; Francesca Negri; Carla Sala; Giuseppe Mancia
Journal:  J Hypertens       Date:  2011-06       Impact factor: 4.844

4.  Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.

Authors:  Mario Cazzola; Germano Bettoncelli; Emiliano Sessa; Claudio Cricelli; Gianluca Biscione
Journal:  Respiration       Date:  2010-02-04       Impact factor: 3.580

Review 5.  Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles.

Authors:  Matthew J Eagleton
Journal:  Vascular       Date:  2012-10       Impact factor: 1.285

Review 6.  Coagulation and anticoagulation in idiopathic pulmonary fibrosis.

Authors:  Michael G Crooks; Simon P Hart
Journal:  Eur Respir Rev       Date:  2015-09

7.  Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm.

Authors:  Fumio Sakamaki; Hideo Oya; Noritoshi Nagaya; Shingo Kyotani; Toru Satoh; Norifumi Nakanishi
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

8.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Authors:  Mette Thomsen; Truls Sylvan Ingebrigtsen; Jacob Louis Marott; Morten Dahl; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

Authors:  Miguel Divo; Claudia Cote; Juan P de Torres; Ciro Casanova; Jose M Marin; Victor Pinto-Plata; Javier Zulueta; Carlos Cabrera; Jorge Zagaceta; Gary Hunninghake; Bartolome Celli
Journal:  Am J Respir Crit Care Med       Date:  2012-05-03       Impact factor: 21.405

View more
  2 in total

1.  Association between Large Arteries Diameter and Heart Function in Subjects Free of Cardiovascular Diseases.

Authors:  Ricarda von Krüchten; Roberto Lorbeer; Annette Peters; Fabian Bamberg; Christopher L Schlett; Blerim Mujaj
Journal:  J Pers Med       Date:  2022-05-28

2.  Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD study.

Authors:  Kana Fujikura; Alessandra Albini; R Graham Barr; Megha Parikh; Julia Kern; Eric Hoffman; Grant T Hiura; David A Bluemke; James Carr; João A C Lima; Erin D Michos; Antoinette S Gomes; Martin R Prince
Journal:  Int J Cardiol       Date:  2021-02-13       Impact factor: 4.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.